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Abstract
Background: The use of peritoneal dialysis (PD) has declined in the United States over the past
decade and technique failure is also reportedly higher in PD compared to hemodialysis (HD), but
there are little data in the United States addressing the factors and outcomes associated with
switching modalities from PD to HD.
Methods: In a prospective cohort study of 262 PD patients enrolled from 28 peritoneal dialysis
clinics in 13 U.S. states, we examined potential predictors of switching from PD to HD (including
demographics, clinical factors, and laboratory values) and the association of switching with
mortality. Cox proportional hazards regression was used to assess relative hazards (RH) of
switching and of mortality in PD patients who switched to HD.
Results: Among 262 PD patients, 24.8% switched to HD; with more than 70% switching within the
first 2 years. Infectious peritonitis was the leading cause of switching. Patients of black race and with
higher body mass index were significantly more likely to switch from PD to HD, RH (95% CI) of
5.01 (1.15–21.8) for black versus white and 1.09 (1.03–1.16) per 1 kg/m2 increase in BMI,
respectively. There was no difference in survival between switchers and non-switchers, RH (95%
CI) of 0.89 (0.41–1.93).
Conclusion: Switching from PD to HD occurs early and the rate is high, threatening long-term
viability of PD programs. Several patient characteristics were associated with the risk of switching.
However, there was no survival difference between switchers and non-switchers, reassuring
providers and patients that PD technique failure is not necessarily associated with poor prognosis.
Background
Hemodialysis (HD) and peritoneal dialysis (PD) repre-
sent the two main modalities for renal replacement ther-
apy. PD is typically considered a home dialysis program,
as the patients have the autonomy to perform the treat-
ment in their home environment, whereas most HD
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patients must travel to a dialysis center, usually three
times a week, to receive their treatment. Despite the
potential benefit of PD compared to HD in quality of life
[1] and associated patient satisfaction [2], prevalent use of
PD has declined in the United States since 1994–1995, by
as much as 67% in some regions of the country [3]. The
number of incident end-stage renal disease (ESRD)
patients initiating PD has also declined over the same
time period [3]. This decline in PD utilization has been
observed not only in the United States but also in Europe
and elsewhere [3,4]. Technique failure is known to be
much higher in PD than HD patients [5-7] and this likely
plays a significant role in the declining prevalence of PD
utilization. Peritonitis has been described as one of the
leading causes of transfer from PD to HD [7-9] and only a
small group of patients can return to PD after severe peri-
tonitis and Tenckhoff catheter removal [10].
Over the past decade, very few studies in the United Sates
have analyzed both the cause of switching from PD to HD
and the timing of this switching process after initiation of
PD. Further, there is a paucity of studies, particularly in
the United States, aimed at identifying risk factors associ-
ated with switching from PD to HD in ESRD patients and
subsequent patient outcomes. The purpose of this study
was to determine patient characteristics associated with
the risk of switching from PD to HD and to assess patient
survival following dialysis modality switches in a cohort
of incident peritoneal dialysis patients.
Methods
Study design and research population
The Choices for Healthy Outcomes in Caring for ESRD
(CHOICE) is a national prospective cohort study of inci-
dent dialysis patients [11]. For the purposes of this study,
we limited our sample to 262 white and black peritoneal
dialysis patients from the CHOICE cohort. From October
1995 to June 1998, participants from 13 states were
enrolled at 28 clinics offering peritoneal dialysis and asso-
ciated with Dialysis Clinic, Inc. (Nashville, TN; n = 178),
New Haven CAPD (New Haven, CT; n = 82) or St. Rap-
hael's Hospital (New Haven, CT; n = 2). Eligibility criteria
for enrollment included ability to provide informed con-
sent for participation, age older than 17 years, and ability
to speak English or Spanish. Median time from start of
peritoneal dialysis to enrollment was 29 days, with 99%
enrolling within 4 months of initiating dialysis. All partic-
ipants gave written informed consent after Institutional
Review Boards for Johns Hopkins University and clinical
centers approved the study protocol.
Data collection
Dialysis modality and switching
Dialysis modality was defined as the modality in use at 4
weeks after enrollment in the study (an average of 10
weeks after starting dialysis). This information was
obtained from clinic records. The initial dialysis modality
information was abstracted from the Centers for Medicare
and Medicaid Services (CMS) ESRD Medical Evidence
Report (Form 2728). All forms of PD (continuous ambu-
latory PD, continuous cycling PD and intermittent cycling
PD) were combined as a single category. Patients were
considered to have switched to hemodialysis (HD) when
they changed from PD to HD and remained on the latter
modality for at least 30 days. Causes of switch from PD to
HD were ascertained from comprehensive chart review.
Patients were censored for time to switch at transplanta-
tion, loss to follow-up, death, or last date of follow-up
(December 31, 2004).
Demographic and clinical data
All patients completed a baseline self-report question-
naire and provided information on demographics, health
behaviors, work history, medical history, and distance to
dialysis unit. Late referral was defined as <4 months
between first nephrologist evaluation and start of dialysis,
as described previously [12]. Residual urine output,
obtained from the patient baseline self-report question-
naire, was defined as the ability to make at least 250 cc (1
cup) of urine per day. Body mass index (BMI) was calcu-
lated using the standard formula weight (in kg)/[height
(in meters)]2, based on the height and weight reported on
the 2728 form. Comorbidity, referring to medical condi-
tions other than the primary disease itself and the severity
of those conditions, was assessed using the ICED, a med-
ical record-derived index that has been demonstrated to
predict death in dialysis populations [13,14]. ICED scores
range from 0 to 3, with 3 as the highest severity level. It is
a measure of both the presence and severity of comorbid
conditions, as described previously. Baseline data for rou-
tine patient care were available for the following labora-
tory values: serum albumin, hemoglobin, total
cholesterol, and serum creatinine. High-sensitivity C-reac-
tive protein (CRP) level was assessed at a median of 5.0
months from dialysis initiation, using a colorimetric com-
petitive enzyme-linked immunosorbent assay (coefficient
of variation, 8.9%). Glomerular filtration rate (GFR)
before dialysis initiation was estimated by the six-variable
Modification of Diet in Renal Disease (MDRD) equation
using serum creatinine obtained from the CMS Form
2728 [15].
Mortality ascertainment
Mortality information was ascertained from clinic report,
medical records, National Death Index and CMS (death
notification forms and Social Security records). Follow-up
for mortality continued until death (n = 88), transplanta-
tion (n = 69), loss to follow-up [when patients left the
study or study clinic (n = 97)], or the last follow-up date
of December 31, 2004 (n = 8). Patients were followed forBMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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mortality for up to 8.9 years (average follow-up, 2 years).
In sensitivity analyses, we also assessed mortality without
loss to follow-up, by including deaths tracked by passive
follow-up through death certificates of patients who left
the study or the study clinic.
Statistical analysis
We compared characteristics of patients who switched
(switchers) to hemodialysis with those patients who
remained on PD (non-switchers) by using t tests for con-
tinuous variables and Pearson's χ2 tests for categorical var-
iables. CRP was log-transformed to reduce skewness of
distribution.
We used time-dependent Cox proportional hazards mod-
els to assess the risk factors for switching by analyzing the
time to first switch from peritoneal dialysis to hemodialy-
sis. Time-dependent analyses were performed to reduce
lead-time bias, since, by definition, those who switched
modality had to survive at least until the switch. In these
analyses, all patients started as non-switchers, and if the
patient switched the patient then became a switcher in the
analyses. In multivariable models, we adjusted for poten-
tial confounders, including variables associated with both
baseline modality and switching. We also used Cox pro-
portional hazards models to assess the mortality risk of
patients on peritoneal dialysis who switched to hemodial-
ysis versus patients who remained on peritoneal dialysis,
independent of differences in demographics (e.g., age,
race, and employment status), clinical factors (e.g., ICED
comorbidity score, diabetes mellitus status, history of car-
diovascular disease, body mass index, and baseline resid-
ual urine output), and laboratory values (e.g., serum
albumin and creatinine).
We also examined whether the mortality risk was similar
by year of follow-up and among persons with different
clinical characteristics by performing Cox proportional
hazards analyses in subpopulations based on survival
time, diabetes mellitus status, history of cardiovascular
disease, baseline residual urine output and baseline serum
albumin (< 3.5 g/dl versus ≥ 3.5 g/dl). We formally tested
for interactions that had been found to be significant in
previous studies by including interaction terms and test-
ing their statistical significance in the full population
models. Furthermore, we tested for and found no devia-
tions from the proportional hazards assumption by exam-
ining the global test of Schoenfeld residuals, both overall
and within each follow-up year. Finally, we accounted for
possible dependence of observations within clinics [16]
by performing fixed-effects modeling clustered on the
dialysis clinic. Statistical analyses were performed using
Stata version 8.2 (StataCorp, College Station, TX).
Results
Patient characteristics
Among the 262 peritoneal dialysis patients, 24.8%
switched to hemodialysis during the study period. PD
patients who switched to HD had higher BMI and serum
creatinine at baseline and were less likely to be white and
to have residual urine output at both baseline and 1 year
of follow-up. There were no other demographic, clinical
or laboratory differences between PD switchers and non-
switchers at baseline (Table 1).
Causes of switching and time to switch from peritoneal 
dialysis to hemodialysis
More than 40% of the PD patients who switched to HD
did so within the first year after starting PD and more than
70% within the first two years (Figure 1). Infections (peri-
tonitis and catheter-related) (36.9%) were the leading
cause of switching from PD to HD, followed by cardiovas-
cular (fluid overload) causes (18.5%). Less common
causes of switching from PD to HD included abdominal
surgery, pancreatitis/malnutrition, decreased mental
capacity and abdominal wall defect (Table 2). Infectious
peritonitis was a leading cause of switch from PD to HD
during most of the follow-up period, whereas cardiovas-
cular/fluid overload as a cause of switch became more
dominant after the first year on peritoneal dialysis (Figure
2). Patients who switched due to infectious peritonitis ver-
sus any other cause were younger (47.1 versus 54.7 years,
P = 0.02) and less likely to be white (52.2% versus 83.3%,
P = 0.007); otherwise there were no other significant dif-
ferences between these patients.
Risk factors associated with switching from peritoneal 
dialysis to hemodialysis
In the unadjusted model, PD patients of black race were
nearly 3 times more likely than white PD patients to
switch from PD to HD; this risk became stronger after
adjustment (Table 3). Patients who were less educated
were 2.5 times more likely to switch from PD to HD, com-
pared to patients who had at least a high school educa-
tion; however, this association was not statistically
significant. Patients living 30 miles or more from the dial-
ysis clinic were 58% less likely to switch from PD to HD
compared to patients living fewer than 30 miles from the
dialysis clinic; but this association was marginally statisti-
cally significant. In both unadjusted and adjusted analy-
ses, the risk of switching from PD to HD significantly
increased by about 10% for each 1 kg/m2 higher BMI. In
the unadjusted analysis, for each 1 mg/dl higher serum
baseline creatinine, there was a 13% increased risk of
switching from PD to HD; however, this relationship was
no longer statistically significant after adjustment. We
found no significant risk of switching from PD to HD by
age, employment status, or diabetes mellitus status (Table
3). Similarly, in sensitivity analyses, Index of CoexistentBMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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Table 1: Patient characteristics by peritoneal dialysis switching status
Characteristic N Non-switchers Switchers P
Total 262 197 (75.2%) 65 (24.8%) --
Demographic
Mean age at enrollment, years 262 54.7 ± 15.4 52.0 ± 13.0 0.202
Sex (% female) 262 42.1 47.7 0.433
Race (% white) 262 83.8 72.3 0.042
Education (% high school graduate) 225 84.2 75.4 0.131
Employment (% working) 262 28.4 20.0 0.181
Marital Status (% married) 238 68.9 62.3 0.341
Distance from clinic (% >30 miles) 216 28.3 28.1 0.973
Clinical
Smoking status (% ever smoker) 227 61.5 60.7 0.914
Modality at start, from 2728 (% HD) 256 7.8 9.4 0.693
ICED score (%) 262 0.848
≤ 1 50.3 46.2
2 25.4 27.7
3 24.4 26.2
Diabetes (% diabetic) 262 49.2 58.5 0.197
History of CVD (% positive) 262 52.3 41.5 0.133
History of CHD (% positive) 262 41.1 32.3 0.207
History of CHF (% positive) 262 40.6 29.2 0.101
Primary cause of renal failure (%) 259 0.341
Diabetes mellitus 44.8 53.9
Hypertension 10.8 6.2
Glomerulonephritis 44.3 40.0
Late referral (% <4 months) 198 21.7 16.4 0.404
BMI, kg/m2 245 25.9 ± 5.6 28.2 ± 6.0 0.006
Residual urine output (%) 186 0.018
Not at baseline or follow-up at 1 year 14.6 19.6BMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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Disease (ICED) and residual urine output were not asso-
ciated with the risk of switching from PD to HD (data not
shown).
Mortality risk associated with switching from peritoneal 
dialysis to hemodialysis
The mortality rate per 100 patient-years was 18.5 for PD
non-switchers versus 13.5 for PD patients who switched
to HD (Table 4). The cumulative mortality did not differ
between switchers and non-switchers (Figure 3). In the
unadjusted analyses, switchers had a 6% decreased risk of
death but the association was not statistically significant.
After adjustment for demographics, clinical factors, and
laboratory values, there was an 11% decreased risk of
death in PD switchers compared to non-switchers but the
results were not statistically significant (Table 4).
In our sensitivity analyses, we found no significant
decreased risk of death for PD switchers versus non-
switchers by year of follow-up (1st and 2nd years) or after
stratification by diabetes mellitus status, history of cardio-
vascular disease, baseline residual urine output, and base-
line serum albumin (< 3.5 g/dl versus ≥ 3.5 g/dl) (data not
shown). Additionally, when we examined the effects of
including passive follow-up in our mortality data, results
were similar and non-statistically significant (data not
shown).
Discussion
This prospective cohort study of incident PD patients
showed that about 25% of patients switched to HD over
time, with more than 70% of the switching occurring
within the first 2 years of treatment. Peritonitis was the
leading cause of this modality change. In this U.S. pro-
spective cohort study, the leading independent predictors
of dialysis modality switching from PD to HD were black
race and higher BMI. Importantly, there was no statisti-
cally significant survival difference between PD patients
who switched to HD compared to those who remained on
PD.
At the end of 2005, only about 7.6% of U.S. dialysis
patients were treated with PD, and this prevalence has
been declining since the mid-1990s [3]. One of the factors
certainly contributing to this low PD prevalence remains
the unacceptable high transfer rate from PD to HD
described in several cohorts [7,17-22]. In an older Italian
study with long follow-up, 18% of PD patients switched
modality, as compared to 2.8% of the HD patients [7]. In
our U.S. incident cohort, this switching rate was 25% for
PD patients switching to HD, compared to 5% for HD
patients switching to PD [18]. In the Netherlands Cooper-
At baseline but not at follow-up at 1 year 17.7 33.9
At baseline and at follow-up at 1 year 67.7 46.4
Laboratory
Mean baseline albumin, g/dl 248 3.57 ± 0.44 3.64 ± 0.38 0.316
Mean baseline hemoglobin, g/dl 246 11.3 ± 1.5 11.3 ± 1.5 0.766
Median CRP (IQR), μg/dl 162 2.6 (1.1–6.2) 3.5 (1.6–5.7) 0.638
Baseline creatinine, g/dl 252 7.08 ± 2.66 7.94 ± 2.63 0.029
Baseline cholesterol, mg/dl 220 207 ± 53 210 ± 57 0.746
Baseline GFR, cc/minute/1.73 m2 254 10.5 ± 0.26 10.3 ± 0.45 0.721
*By t-test (continuous variables) or χ2 test (categorical variables)
Table 1: Patient characteristics by peritoneal dialysis switching status (Continued)
Table 2: Causes of switching from peritoneal dialysis to 
hemodialysis
Causes of Switching Number (%)
N = 65
Infection (peritonitis and catheter-related) 24 (36.9%)
Cardiovascular (fluid overload) 12 (18.5%)
Abdominal surgery 8 (12.3%)
Pancreatitis/malnutrition 7 (10.8%)
Decreased mental capacity 2 (3.1%)
Abdominal wall defect 1 (1.6%)
Unknown 11 (16.9%)BMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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ative Study on the Adequacy of Dialysis, 3-year technique
survival was only 53% [21]. In a more recent U.S. cohort,
Guo et al. [17] showed a significant trend towards decreas-
ing transfer rates to HD during the first year on PD, from
19.6% in 1999 to 17.2% in 2001.
In agreement with previous studies, we found that infec-
tions remain the leading cause of switching from PD to
HD, followed by cardiovascular causes, mainly fluid over-
load [9,17,23]. Infectious causes, which are generally pre-
ventable, were responsible for 28% of the transfers from
PD to HD in a recent study by Mujais et al. [24]. However,
in the early 1990s, this cause of dialysis modality transfer
from PD to HD was reported to be as high as 49% [25].
Over the past few years, the use of the twin-bag and Y-set
systems has certainly helped to decrease the peritonitis
rate [26]. Ultrafiltration failure, leading to fluid overload,
which was the next most important cause of transfer from
PD to HD in our study, has been shown to increase with
time on PD [23,27]; however, in our cohort, this trend
was observed only during the first 18 months. We did not
find an increasing number of ultrafiltration failures in our
PD patients, possibly because a much smaller number of
patients switched from PD to HD after 2 years. This ultra-
Cumulative percentage of peritoneal dialysis patients by time from first dialysis to first switch to hemodialysis (switchers only) Figure 1
Cumulative percentage of peritoneal dialysis patients by time from first dialysis to first switch to hemodialysis 
(switchers only).BMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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filtration failure is a consequence of morphological and
functional changes of the peritoneal membrane, includ-
ing increased small solute transport and lymphatic
absorption, over time [28,29]. Loss of residual renal func-
tion with decreasing urine output observed over time in
this cohort is also another likely mechanism leading to
more fluid overload as a cause of transfer from PD to HD.
We identified several patient characteristics associated
with a higher risk of switching from PD to HD over time.
Patients of black race were 5 times more likely than white
patients to switch from PD to HD. This finding is in
accordance with an older single-center study, which
reported a significantly higher technique failure rate in
black patients (39%) compared to white patients (8%)
[30]. Patients with diabetes mellitus have also been
reported to have a higher transfer rate from PD to HD in
some cohorts [17,24] but certainly not all [31,32]. Similar
to Huisman et al. [31] and Viglino et al. [32], we found no
significant association between diabetes mellitus and
modality transfer from PD to HD, although, in our
cohort, more patients with diabetes mellitus switched to
HD (28.2%) compared to nondiabetics (21.3%). This
lack of statistical significance could be due to our smaller
sample size. Parallel to previous studies, we found no
effect of age on transfer rate from PD to HD [17], suggest-
ing that PD can be performed in any age group with
appropriate support.
There are little data looking at the association of BMI with
technique survival among PD patients. In our study,
higher BMI was independently associated with increasing
risk of switching from PD to HD. This is in concordance
with a recent retrospective cohort study [33] and another
study from Australia and New Zealand, in which PD tech-
nique failure was 17% higher in obese patients compared
to patients with normal BMI [34]. Peritoneal dialysis
patients with higher BMI may be at increased risk for not
Percentage of switching peritoneal dialysis patients by main causes of switch and by time from first peritoneal dialysis to hemo- dialysis switch Figure 2
Percentage of switching peritoneal dialysis patients by main causes of switch and by time from first peritoneal 
dialysis to hemodialysis switch.BMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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only infectious complications and inadequate dialysis but
also peritoneal leaks because of raised intra-abdominal
pressure [35,36]. Although in our study there was a clear
trend towards a lower risk of transfer from PD to HD for
patients living 30 miles or more from their dialysis clinic,
this association was not statistically significant. However,
a recent report from Canada clearly showed a significant
trend toward decreasing PD technique failure with
increasing distance from their nephrologist [37].
The impact of dialysis modality switching from PD to HD
on patient survival remains controversial. We found no
significant difference in survival over time between PD
patients who switched to HD compared to those who
remained on PD. Similar results have been reported in
black patients in the United States [38] and in European
cohorts [7]. However, other studies have shown higher
mortality for PD patients who switched to HD compared
to those who remained on PD [9,19]. In contrast to these
Table 3: Predictors of dialysis modality switching: relative hazards for switching versus non-switching (time to first switch) from 
peritoneal dialysis to hemodialysis
Relative Hazards (95% CI)
Predictors Unadjusted Adjusted*
Age (per 1-year increase) 1.00 (0.98–1.01) 0.98 (0.95–1.01)
Race
White 1.00 (ref.) 1.00 (ref.)
Black 2.79 (1.25–6.23) 5.01 (1.15–21.8)
Education
High school graduate or higher 1.00 (ref.) 1.00 (ref.)
Less than high school graduate 1.64 (0.83–3.23) 2.53 (0.98–6.55)
Employment
Employed 1.00 (ref.) 1.00 (ref.)
Not employed 1.51 (0.76–3.01) 1.81 (0.66–4.94)
Distance to dialysis clinic
Living less than 30 miles from clinic 1.00 (ref.) 1.00 (ref.)
Living 30 miles or more from clinic 0.65 (0.32–1.30) 0.42 (0.17–1.02)
Diabetes
Nondiabetic 1.00 (ref.) 1.00 (ref.)
Diabetic 1.22 (0.71–2.12) 1.79 (0.74–4.33)
BMI (per 1 kg/m2 increase) 1.10 (1.04–1.15) 1.09 (1.03–1.16)
Baseline creatinine (per 1 mg/dl increase) 1.13 (1.02–1.26) 1.13 (0.97–1.33)
Number (%) of patients switching/total number of patients by subpopulation: white, 47/212 (22.2%); black, 18/50 (36.0%); employed, 13/69 (18.8%); 
not employed, 52/193 (26.9%); high school graduate, 46/184 (25.0%); not high school graduate, 15/41 (36.6%); nondiabetic, 27/127 (21.3%); diabetic, 
38/135 (28.2%); living at least 30 miles from dialysis clinic 41/155 (26.5%); living less than 30 miles from dialysis clinic 16/61 (26.2%).
* Adjusted model (n = 195) included age, race, education, employment, distance to dialysis clinic, diabetes mellitus status, BMI, baseline serum 
creatinine.BMC Nephrology 2009, 10:3 http://www.biomedcentral.com/1471-2369/10/3
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reports, Van Biesen et al. [39], found a much better prog-
nosis for PD patients who switched to HD compared to
those remaining on PD. These differences in outcomes
may be explained by differences in case-mix and reasons
for technique failure. Several of these studies, including
our own, showed that PD technique failure does not nec-
essarily indicate worse prognosis after switching to HD;
rather, more importantly, a timely transfer is vital when
severe PD-related complications occur [40].
There are some limitations associated with our study. We
had some, but not detailed, data on residual urine output.
Furthermore, we had no data on peritoneal membrane
characteristics; high peritoneal solute transport has been
associated with PD technique failure and mortality in
observational studies [23,41] but not in a more recent
prospective, randomized, controlled trial [42]. Also,
because of the relatively smaller sample size, we com-
bined automated PD and continuous ambulatory PD. But
recently, Mujais et al. [24], using data from the Baxter
Healthcare Corporation On-Call system reported that
transfer to HD was lower in patients on automated PD
than in patients on continuous ambulatory PD. However,
compared to administrative data, our study provided the
advantage of a prospective incident cohort with detailed
data on comorbidities, laboratory values, and access to
patient charts to determine specific causes of switching.
There was a notable rate of lost to follow-up; however,
mortality results including passive follow-up were similar
to those without passive follow-up. Despite these limita-
tions, our study represents, to our knowledge, one of the
few prospective incident cohort studies specifically in the
United States analyzing in detail switching of incident PD
patients to HD, in terms of rate, timing, predictors and
prognosis.
Conclusion
This prospective study of incident PD patients in the
United States confirmed that the observed early switching
rate from PD to HD remains too high and certainly repre-
sents a significant impediment to the long-term viability
of any PD program. Additional efforts are urgently needed
to continue to prevent PD-related infections, the leading
cause of PD technique failure; also, when antibiotic
response for peritonitis remains inadequate, early Tenck-
hoff catheter removal may help preserve the peritoneal
membrane for future return to PD [43]. Moreover, we
were able to identify important independent risk factors
for switching from PD to HD (BMI and black race). In this
context, more studies are definitely needed to better
understand why black PD patients were more likely to
switch to HD over time. Finally, our findings of no sur-
vival difference between PD switchers and non-switchers
should be reassuring to providers and patients that PD
technique failure is not necessarily associated with poor
prognosis, but a timely transfer in setting of complications
remains important.
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